IZI Medical Products acquires needle assets from Cook Medical

IZI Medical Products, LLC, an interventional radiology medical device company, acquired soft tissue biopsy and breast localization needle assets from Cook Medical. This is IZI’s third add-on acquisition in the last 18 months.

The assets include Quick-Core Biopsy Needle, MReye Breast Localization Coil, and the Kopans and X-Reidy Lesion Localization Needles. 

“We are excited to increase the market penetration of these products through significant investment in domestic and international selling resources, select product enhancements, and new product development,” Greg Groenke, CEO of IZI Medical, said in a prepared statement.

“We were looking for a company that could invest more resources and continue to support these product families, the patients that benefit from them, and the physicians that use them,” Mark Breedlove, vice president of the vascular division at Cook Medical, said in the same statement. 

Breedlove added that Cook Medical has worked with IZI previously and determined they would be the “ideal partner” for such a partnership. 

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.